Argitalpenak (33) MINERVA RODRIGUEZ GARCIA argitalpenak

filter_list

2025

  1. Differences in association between hypoalbuminaemia and mortality among younger versus older patients on haemodialysis

    Clinical Kidney Journal, Vol. 18, Núm. 1

  2. Expression of ADAM17 and serum PTH levels in dialysis patients with and without diabetes: Potential implications for vascular calcification

    Nefrologia, Vol. 45, Núm. 7

  3. Non-Invasive Assessment of Vascular Damage Through Pulse Wave Velocity and Superb Microvascular Imaging in Pre-Dialysis Patients

    Biomedicines, Vol. 13, Núm. 3

2024

  1. Diálogos entre investigadores básicos y clínicos: hiperfosfatemia

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 16, Núm. 4, pp. 149-153

  2. El efecto de las caídas sobre la salud percibida en población general y sus consecuencias clínicas

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 16, Núm. 3, pp. 88-96

  3. Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care

    Nefrologia , Vol. 44, Núm. 2, pp. 241-250

  4. RANKL, but Not R-Spondins, Is Involved in Vascular Smooth Muscle Cell Calcification through LGR4 Interaction

    International Journal of Molecular Sciences, Vol. 25, Núm. 11

  5. Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 4, pp. 618-626

  6. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  7. The regulation of phosphate and its association with alterations in bone and mineral metabolism

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 16, Núm. 4, pp. 113-122

2023

  1. Association of gamma glutamyl transferase in the presence and progression of abdominal aortic calcifications and changes to bone mineral density

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 15, Núm. 3, pp. 93-99

  2. Mineral and Bone Disorders in Chronic Kidney Disease

    Management of Chronic Kidney Disease: A Clinician’s Guide, Second Edition (Springer International Publishing), pp. 239-256

  3. Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis

    Frontiers in Physiology

  4. Should the FRAX tool include other variables to assess fragility-related osteoporotic fractures?

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 15, Núm. 3, pp. 100-105

2022

  1. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

  2. Low-density granulocytes: A new marker of bone deterioration in patients on peritoneal dialysis

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 4, pp. 107-114

  3. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2021

  1. Association of biochemical parameters of bone metabolism with progression and/or development of new aortic calcifications

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 13, Núm. 1, pp. 10-16

  2. Novel Immune Cell Subsets Exhibit Different Associations With Vascular Outcomes in Chronic Kidney Disease Patients—Identifying Potential Biomarkers

    Frontiers in Medicine, Vol. 8

  3. Survival with low- and high-flux dialysis

    Clinical Kidney Journal, Vol. 14, Núm. 8, pp. 1915-1923